Dr. Eduardo Ruiz-Hernandez (firstname.lastname@example.org)
Dr. Eduardo Ruiz-Hernandez is an Associate Professor in Pharmaceutical Chemistry of Nanocarrier Drug Delivery Systems in the School of Pharmacy and Pharmaceutical Sciences (Trinity College Dublin), Principal Investigator in the Trinity Biomedical Sciences Institute (TBSI), and is the recipient of a Starting ERC on smart nanocarriers for drug delivery (REACT – Responsive theranostic nanosystems for advanced cancer treatment, 1.5M€). With more than 14 years’ experience in the research of advanced biomaterials for the diagnosis and treatment of several diseases (mainly cancer), he has participated in 26 highly multidisciplinary collaborative projects funded by a variety of national and international sources (EU FP6/FP7/H2020, BBSRC, Science Foundation Ireland, CTMM The Netherlands, Spanish MICIIN, CIBER-BBN) across 7 countries in diverse scientific fields including nanomedicine, materials chemistry, drug/gene delivery and tissue engineering. His research programme aims to design responsive nanosystems with disease-specific potential that enable ultrasensitive diagnosis and therapy selectivity.
This project has received funding from the European Union’s Horizon 2020 research
and innovation programme under grant agreement No 952259.